ALKS ALKERMES PLC Product Launches 8-K Filing 2023 - Product Launch Alkermes plc announced initial results from a phase 1 study evaluating ALKS 2680 for the treatment of narcolepsy.Get access to all SEC 8-K filings of the ALKERMES PLC